Ofatumumab

From WikiMD.org
Jump to navigation Jump to search
Ofatumumab
TermOfatumumab
Short definitionOEPA - An acronym for a combination of chemotherapy, often used in conjunction with radiation therapy, to treat a specific type of childhood Hodgkin's lymphoma in men. It includes the drugs vincristine sulfate (Oncovin), etoposide, prednisone, and doxorubicin hydrochloride (Adriamycin). 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


ofatumumab - (pronounced) (OH-fa-TOO-moo-mab) medicine used alone or with other medicines to treat certain types of chronic lymphocytic leukaemia. It is also being studied in the treatment of other types of cancer. Ofatumumab attaches to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of leukemia and lymphoma cells. Ofatumumab can block CD20 and help the immune system kill cancer cells. It's a type of monoclonal antibody. Also called Arzerra and HuMax-CD20

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski